209 related articles for article (PubMed ID: 32279431)
1. ASH2L is involved in promotion of endometrial cancer progression via upregulation of PAX2 transcription.
Zeng K; Wu Y; Wang C; Wang S; Sun H; Zou R; Sun G; Song H; Liu W; Sun N; Wei S; Liu W; Su Y; Zhou T; Zhang Y; Zhao Y
Cancer Sci; 2020 Jun; 111(6):2062-2077. PubMed ID: 32279431
[TBL] [Abstract][Full Text] [Related]
2. PAX2 is regulated by estrogen/progesterone through promoter methylation in endometrioid adenocarcinoma and has an important role in carcinogenesis via the AKT/mTOR signaling pathway.
Chen H; Li L; Liu H; Qin P; Chen R; Liu S; Xiong H; Li Y; Yang Z; Xie M; Yang H; Jiang Q
J Pathol; 2024 Apr; 262(4):467-479. PubMed ID: 38185904
[TBL] [Abstract][Full Text] [Related]
3. DNA methylation promotes paired box 2 expression via myeloid zinc finger 1 in endometrial cancer.
Jia N; Wang J; Li Q; Tao X; Chang K; Hua K; Yu Y; Wong KK; Feng W
Oncotarget; 2016 Dec; 7(51):84785-84797. PubMed ID: 27764784
[TBL] [Abstract][Full Text] [Related]
4. Histone acetyltransferase MOF is involved in suppression of endometrial cancer and maintenance of ERα stability.
Wu Y; Zeng K; Wang C; Wang S; Sun H; Liu W; Wang X; Niu J; Cong SY; Zhou X; Zhao Y
Biochem Biophys Res Commun; 2019 Feb; 509(2):541-548. PubMed ID: 30598260
[TBL] [Abstract][Full Text] [Related]
5. Absent, small or homeotic 2-like protein (ASH2L) enhances the transcription of the estrogen receptor α gene through GATA-binding protein 3 (GATA3).
Qi J; Huo L; Zhu YT; Zhu YJ
J Biol Chem; 2014 Nov; 289(45):31373-81. PubMed ID: 25258321
[TBL] [Abstract][Full Text] [Related]
6. Ash2l interacts with Tbx1 and is required during early embryogenesis.
Stoller JZ; Huang L; Tan CC; Huang F; Zhou DD; Yang J; Gelb BD; Epstein JA
Exp Biol Med (Maywood); 2010 May; 235(5):569-76. PubMed ID: 20463296
[TBL] [Abstract][Full Text] [Related]
7. PRMT5 promotes progression of endometrioid adenocarcinoma via ERα and cell cycle signaling pathways.
Mei S; Ge S; Wang J; Li H; Jing X; Liang K; Zhang X; Xue C; Zhang C; Zhang T
J Pathol Clin Res; 2021 Mar; 7(2):154-164. PubMed ID: 33416213
[TBL] [Abstract][Full Text] [Related]
8. Fgfr3 is a transcriptional target of Ap2delta and Ash2l-containing histone methyltransferase complexes.
Tan CC; Walsh MJ; Gelb BD
PLoS One; 2009 Dec; 4(12):e8535. PubMed ID: 20046871
[TBL] [Abstract][Full Text] [Related]
9. Expression pattern of PAX2 in hyperplastic and malignant endometrium.
Kahraman K; Kiremitci S; Taskin S; Kankaya D; Sertcelik A; Ortac F
Arch Gynecol Obstet; 2012 Jul; 286(1):173-8. PubMed ID: 22274645
[TBL] [Abstract][Full Text] [Related]
10. Transcription factor Ap2delta associates with Ash2l and ALR, a trithorax family histone methyltransferase, to activate Hoxc8 transcription.
Tan CC; Sindhu KV; Li S; Nishio H; Stoller JZ; Oishi K; Puttreddy S; Lee TJ; Epstein JA; Walsh MJ; Gelb BD
Proc Natl Acad Sci U S A; 2008 May; 105(21):7472-7. PubMed ID: 18495928
[TBL] [Abstract][Full Text] [Related]
11. ZNF479 downregulates metallothionein-1 expression by regulating ASH2L and DNMT1 in hepatocellular carcinoma.
Wu YJ; Ko BS; Liang SM; Lu YJ; Jan YJ; Jiang SS; Shyue SK; Chen L; Liou JY
Cell Death Dis; 2019 May; 10(6):408. PubMed ID: 31138789
[TBL] [Abstract][Full Text] [Related]
12. ARID1 and BRG1 Expression in Endometrial Cancer.
Kontomanolis EN; Symeonidis P; Nikolettos K; Perros P; Rody A; Tsikouras P; Nikolettos N; Giatromanolaki A
In Vivo; 2024; 38(3):1260-1265. PubMed ID: 38688602
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of ERM/ETV5 correlates with the degree of myometrial infiltration in endometrioid endometrial carcinoma.
Planagumà J; Abal M; Gil-Moreno A; Díaz-Fuertes M; Monge M; García A; Baró T; Xercavins J; Reventós J; Alameda F
J Pathol; 2005 Dec; 207(4):422-9. PubMed ID: 16175655
[TBL] [Abstract][Full Text] [Related]
14. ASH2L, a COMPASS core subunit, is involved in the cell invasion and migration of triple-negative breast cancer cells through the epigenetic control of histone H3 lysine 4 methylation.
Batbayar G; Ishimura A; Lyu H; Wanna-Udom S; Meguro-Horike M; Terashima M; Horike SI; Takino T; Suzuki T
Biochem Biophys Res Commun; 2023 Aug; 669():19-29. PubMed ID: 37262949
[TBL] [Abstract][Full Text] [Related]
15. Establishment and characterization of VOA1066 cells: An undifferentiated endometrial carcinoma cell line.
Wang Y; Tao VL; Shin CY; Salamanca C; Chen SY; Chow C; Köbel M; Ben-Neriah S; Farnell D; Steidl C; Mcalpine JN; Gilks CB; Huntsman DG
PLoS One; 2020; 15(10):e0240412. PubMed ID: 33052929
[TBL] [Abstract][Full Text] [Related]
16. Hypomethylation of the CTCFL/BORIS promoter and aberrant expression during endometrial cancer progression suggests a role as an Epi-driver gene.
Hoivik EA; Kusonmano K; Halle MK; Berg A; Wik E; Werner HM; Petersen K; Oyan AM; Kalland KH; Krakstad C; Trovik J; Widschwendter M; Salvesen HB
Oncotarget; 2014 Feb; 5(4):1052-61. PubMed ID: 24658009
[TBL] [Abstract][Full Text] [Related]
17. Assessing the prognostic value of PAX2 and PTEN in endometrial carcinogenesis.
Rewcastle E; Varhaugvik AE; Gudlaugsson E; Steinbakk A; Skaland I; van Diermen B; Baak JP; Janssen EAM
Endocr Relat Cancer; 2018 Dec; 25(12):981-991. PubMed ID: 30400021
[TBL] [Abstract][Full Text] [Related]
18. RIZ1 is regulated by estrogen and suppresses tumor progression in endometrial cancer.
Yang T; Ren C; Jiang A; Yu Z; Li G; Wang G; Zhang Q
Biochem Biophys Res Commun; 2017 Jul; 489(2):96-102. PubMed ID: 28528974
[TBL] [Abstract][Full Text] [Related]
19. Oestrogen receptor-mediated expression of Olfactomedin 4 regulates the progression of endometrial adenocarcinoma.
Duan C; Liu X; Liang S; Yang Z; Xia M; Wang L; Chen S; Yu L
J Cell Mol Med; 2014 May; 18(5):863-74. PubMed ID: 24495253
[TBL] [Abstract][Full Text] [Related]
20. Hypomethylation-linked activation of PAX2 mediates tamoxifen-stimulated endometrial carcinogenesis.
Wu H; Chen Y; Liang J; Shi B; Wu G; Zhang Y; Wang D; Li R; Yi X; Zhang H; Sun L; Shang Y
Nature; 2005 Dec; 438(7070):981-7. PubMed ID: 16355216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]